This inventor holds 1 USPTO granted patent. Top assignee: Gb002, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Marcus Schestopol: Inventor of a Crystalline Pharmaceutical Form
Introduction
Marcus Schestopol is an inventor associated with San Diego, California. His patent work concerns crystalline forms of a pharmaceutical compound and their potential use in treatment related to pulmonary arterial hypertension (PAH).
Latest Patents
Schestopol is named on 1 patent: “Crystalline Forms of N-{3-[(1S)-1-{[6-(3,4-Dimethoxyphenyl)pyrazin-2-yl]amino}ethyl]phenyl}-5-methylpyridine-3-carboxamide and Related Products and Methods.” The patent describes crystalline forms of the compound, along with pharmaceutical compositions and dosage forms containing those forms. It also covers related methods for modulating kinases and specifically discusses treatment of PAH.
Career Highlights
The available information identifies Schestopol’s patent contribution in pharmaceutical research and development. The invention focuses on the compound’s crystalline forms and their potential application in medicines.
Collaborations
Schestopol is associated with Gb002, Inc. His listed collaborators include Beili Zhang and David Paisner.
Conclusion
Marcus Schestopol’s documented invention centers on crystalline pharmaceutical forms and related compositions and methods, including potential applications for PAH treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile